122 related articles for article (PubMed ID: 19438532)
1. Computerized quantification of psoriasis lesions with colour calibration: preliminary results.
Iyatomi H; Oka H; Hagiwara M; Miyake A; Kimoto M; Ogawa K; Tanaka M
Clin Exp Dermatol; 2009 Oct; 34(7):830-3. PubMed ID: 19438532
[TBL] [Abstract][Full Text] [Related]
2. Area assessment of psoriasis lesions for PASI scoring.
Fadzil MH; Ihtatho D; Affandi AM; Hussein SH
J Med Eng Technol; 2009; 33(6):426-36. PubMed ID: 19557605
[TBL] [Abstract][Full Text] [Related]
3. Objective assessment of psoriasis erythema for PASI scoring.
Ahmad Fadzil MH; Ihtatho D; Mohd Affandi A; Hussein SH
J Med Eng Technol; 2009; 33(7):516-24. PubMed ID: 19639508
[TBL] [Abstract][Full Text] [Related]
4. Tacalcitol in the treatment of psoriasis vulgaris: the Spanish experience.
Lecha M; Mirada A; López S; Artés M;
J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):414-7. PubMed ID: 15987284
[TBL] [Abstract][Full Text] [Related]
5. Clinical experience with the use of cyclosporin A in psoriasis. Results of a retrospective study.
Ojeda R; Sánchez Regaña M; Massana J; Oliete R; Umbert P
J Dermatolog Treat; 2005; 16(4):238-41. PubMed ID: 16249146
[TBL] [Abstract][Full Text] [Related]
6. Computer-aided analysis with Image J for quantitatively assessing psoriatic lesion area.
Sun Z; Wang Y; Ji S; Wang K; Zhao Y
Skin Res Technol; 2015 Nov; 21(4):437-43. PubMed ID: 25661416
[TBL] [Abstract][Full Text] [Related]
7. Application of machine vision to assess involved surface in patients with psoriasis.
Savolainen L; Kontinen J; Röning J; Oikarinen A
Br J Dermatol; 1997 Sep; 137(3):395-400. PubMed ID: 9349336
[TBL] [Abstract][Full Text] [Related]
8. Initial experience with routine administration of etanercept in psoriasis.
de Groot M; Appelman M; Spuls PI; de Rie MA; Bos JD
Br J Dermatol; 2006 Oct; 155(4):808-14. PubMed ID: 16965432
[TBL] [Abstract][Full Text] [Related]
9. A Simplified Psoriasis Area Severity Index (SPASI) for rating psoriasis severity in clinic patients.
Louden BA; Pearce DJ; Lang W; Feldman SR
Dermatol Online J; 2004 Oct; 10(2):7. PubMed ID: 15530297
[TBL] [Abstract][Full Text] [Related]
10. A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment.
Hroch M; Chladek J; Simkova M; Vaneckova J; Grim J; Martinkova J
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):19-24. PubMed ID: 18031504
[TBL] [Abstract][Full Text] [Related]
11. Topical calcipotriol in the treatment of intertriginous psoriasis.
Kienbaum S; Lehmann P; Ruzicka T
Br J Dermatol; 1996 Oct; 135(4):647-50. PubMed ID: 8915166
[TBL] [Abstract][Full Text] [Related]
12. Eosinophils, pruritus and psoriasis: effects of treatment with etretinate or cyclosporin-A.
Schopf RE; Hultsch T; Lotz J; Bräutigam M
J Eur Acad Dermatol Venereol; 1998 Nov; 11(3):234-9. PubMed ID: 9883435
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporin A treatment in severe childhood psoriasis.
Pereira TM; Vieira AP; Fernandes JC; Sousa-Basto A
J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):651-6. PubMed ID: 16836490
[TBL] [Abstract][Full Text] [Related]
14. Clinical usefulness and patient satisfaction for treatment with low-dose cyclosporin administration in patients with moderate psoriasis vulgaris.
Abe M; Ishibuchi H; Syuto T; Sogabe Y; Yokoyama Y; Ishikawa O
J Dermatol; 2007 May; 34(5):290-3. PubMed ID: 17408436
[TBL] [Abstract][Full Text] [Related]
15. Clinical and immunohistochemical assessment of the effect of cyclosporin in keratinocytes and dermal dendrocytes in psoriasis.
Lago E; Carneiro S; Cuzzi T; Magalhães G; Cássia F; Pessanha F; Ramos-e-Silva M
J Cutan Pathol; 2007 Jan; 34(1):15-21. PubMed ID: 17214849
[TBL] [Abstract][Full Text] [Related]
16. A study examining inter-rater and intrarater reliability of a novel instrument for assessment of psoriasis: the Copenhagen Psoriasis Severity Index.
Berth-Jones J; Thompson J; Papp K;
Br J Dermatol; 2008 Aug; 159(2):407-12. PubMed ID: 18565187
[TBL] [Abstract][Full Text] [Related]
17. Calcipotriol ointment versus cream in psoriasis vulgaris.
Duweb G; Aldebani S; Elzorghany A; Benghazil M; Alhaddar J
Int J Clin Pharmacol Res; 2003; 23(2-3):47-51. PubMed ID: 15018018
[TBL] [Abstract][Full Text] [Related]
18. Effect of psoriasis treatment on plasma concentrations of metalloproteinase-1 and tissue inhibitor of metalloproteinases-1.
Flisiak I; Myśliwiec H; Chodynicka B
J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):418-21. PubMed ID: 15987285
[TBL] [Abstract][Full Text] [Related]
19. A comparison of two cyclosporine dosage regimens for the treatment of severe psoriasis.
Yoon HS; Youn JI
J Dermatolog Treat; 2007; 18(5):286-90. PubMed ID: 17852632
[TBL] [Abstract][Full Text] [Related]
20. Objective measurement of erythema in psoriasis using digital color photography with color calibration.
Raina A; Hennessy R; Rains M; Allred J; Hirshburg JM; Diven DG; Markey MK
Skin Res Technol; 2016 Aug; 22(3):375-80. PubMed ID: 26517973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
